Category: Endocrinology and Metabolism
95 Physicians and Advanced Practice Providers Awarded 2024 Carolina Care Excellence
Each year, UNC Hospitals administers the Press Ganey Medical Practice survey to solicit feedback from patients. The survey asks our patients about their likelihood of recommending their provider’s practice to their friends and family. This year, 205 UNC physicians and advanced practice providers received the highest recommendations, which places them in the top quartile nationall … Read more
Dr. Buse Honored with 2024 Outstanding Physician Clinician in Diabetes Award
The American Diabetes Association (ADA) has announced the recipients of the 2024 National Scientific and Health Care Achievement Awards, recognizing individuals who have significantly advanced diabetes care, education and research. Among the esteemed awardees is John Buse, MD, PhD, the Verne S. Caviness Distinguished Professor of Medicine in the UNC Division of Endocrinology and … Read more
Accolades, Awards and Appointments Archive
Congratulations to department faculty who received the following accolades, awards and appointments, March 1 – March 31, 2024. Katherine Reeder Hayes, MD, MBA, has been promoted to professor of medicine. Brian Jensen, MD, has been promoted to professor of medicine. Laura Blanchard, PA-C, served on the planning committee for the APP Oncology Summit, a regional CME conference desig … Read more
Featured Staff Member: Jill Cunnup
Jill Cunnup is the director of clinical research administration for the Division of Endocrinology and Metabolism. She has been with UNC for almost 23 years and says she really enjoys working with her colleagues. As many know, Jill wears flip flops almost all the time. Learn the about the unique reason why, below.
Metformin Use Shows No Increase in Gastrointestinal Adverse Events During GLP-1RA Initiation
A recent study analyzing data from four pivotal clinical trials—LEADER, STEP 2, SUSTAIN 6, and PIONEER 6—evaluated the impact of concomitant metformin use on gastrointestinal adverse events during the initiation and titration of glucagon-like peptide 1 receptor agonists (GLP-1RA). Klara Klein, MD, PhD, assistant professor of medicine in the UNC Division of Endocrinology led the 1 … Read more
Department of Medicine Grants & Funding: November 1 – November 30, 2023
Division of Hematology Rafal Pawlinski, PhD, and Brandi Reeves, MD, were awarded a one-year $75,000 UNC School of Medicine Phase 2 Translational Team Science Award (TTSA) for their project, “evaluating the role of hypoxia inducible factors in endothelial and hematopoietic cells in myeloproliferative neoplasms.” Division of Endocrinology & Metabolism Emily Pfaff, PhD, spoke ab … Read more
Buse, Smith Recognized in Global Highly Cited Researchers 2023 List
John Buse, MD, PhD, and Sidney Smith Jr., MD, along with 18 UNC School of Medicine and 21 other UNC-Chapel Hill researchers have been named in Clarivate’s 2023 list of Highly Cited Researchers™. These scientific pioneers from around the world are drawn from the publications that rank in the top 1% by citations for field and publication year in the Web of Science™ citation index. … Read more
Faculty and Staff in the News Throughout October
The clickable links below navigate directly to outside media articles which featured Department of Medicine faculty throughout the month of October. Evan S. Dellon, MD, MPH, was featured in a New York Times article that depicts a patient’s experience with EoE. Faculty and fellows in the Division of Pulmonary Diseases & Critical Care Medicine attended the NC Thoracic Society … Read more
UNC Joins Osteoporosis Clinical Trial to Test Specialist-Fracture Liaison Service
Donald Caraccio, MD, principal investigator and assistant professor medicine, and Maya Styner, MD, associate professor of medicine, will lead a clinical site for the RESTORE study- REducing future fractureS and improving ouTcOmes of fRagility fracturE. Bones in patients with osteoporosis often become fragile and have an increased risk for fracture or break. Known as fragility … Read more
-
Study Shows Weight Loss Drug Reduces Cardiovascular Risk by 20% in Overweight, Obese Adults
A new study shows semaglutide 2.4 mg (Wegovy), a weekly injected prescription medication for overweight adults, may prevent major adverse cardiovascular events (MACEs) such as cardiovascular death, non-fatal heart attack or non-fatal stroke. Novo Nordisk released the results of the significant clinical trial called SELECT. The trail studied the effects of Wegovy on people with ca … Read more
Featured Advanced Practice Provider: Bonnie Alexander
Bonnie Alexander, PA-C, RDN, originally from California, is on our Diabetes Care Team. She began her career as a registered dietitian before finding her love for patient care as a physician assistant. Outside of work Bonnie enjoys doing hot yoga, reading, and traveling. Grain bowls are one of her favorite foods!
Higher Doses of Oral Semaglutide Improves Blood Sugar Control and Weight Loss
A multicenter, randomized, phase 3b trial, done in collaboration with a UNC School of Medicine researcher, found that once-daily oral semaglutide taken at higher doses of 25mg and 50mg improved regulation of blood sugar levels and weight loss compared to the standard 14 mg dose. Diabetes is a progressive disease that affects one’s ability to control blood sugar levels. For many p … Read more